[L-DOPA with the decarboxylase inhibitor Ro 4-4602 in the treatment of Parkinson's disease].
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D004295:Dihydroxyphenylalanine / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*; D011736:Pyridoxine / Q000627:therapeutic use
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D004295:Dihydroxyphenylalanine; D011736:Pyridoxine
Ervaringen met L-DOPA in combinatie met de decarboxylaseremmer Ro 4-4602 bij de behandeling van de ziekte van Parkinson.